These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11923805)

  • 1. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging.
    Dubach P; Myers J; Bonetti P; Schertler T; Froelicher V; Wagner D; Scheidegger M; Stuber M; Luchinger R; Schwitter J; Hess O
    Am Heart J; 2002 Apr; 143(4):676-83. PubMed ID: 11923805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: application of magnetic resonance myocardial tagging.
    Myers J; Wagner D; Schertler T; Beer M; Luchinger R; Klein M; Rickli H; Muller P; Mayer K; Schwitter J; Dubach P
    Am Heart J; 2002 Oct; 144(4):719-25. PubMed ID: 12360170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction. Doppler Flow and Echocardiology in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy Study Group.
    Lewis BS; Poole-Wilson PA
    Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():407-18. PubMed ID: 7947383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
    Clements IP; Miller WL
    Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
    Hori M; Nagai R; Izumi T; Matsuzaki M
    Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N
    J Am Coll Cardiol; 1997 Apr; 29(5):1060-6. PubMed ID: 9120160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
    Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
    Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size.
    Hu K; Gaudron P; Ertl G
    J Am Coll Cardiol; 1998 Mar; 31(3):692-700. PubMed ID: 9502655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between exercise capacity and left ventricular function at rest in patients with heart insufficiency: radionuclide continuous monitoring of left ventricular function].
    Pace L; Nappi A; Imbriaco M; Cuocolo A; Varrone A; Romano M; Trimarco B; Salvatore M
    Radiol Med; 2000 Sep; 100(3):120-5. PubMed ID: 11148876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure.
    Witte KK; Thackray S; Nikitin NP; Cleland JG; Clark AL
    Eur J Heart Fail; 2005 Jun; 7(4):612-7. PubMed ID: 15921802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice].
    Ageev FT; Zhubrina ES; Ovchinnikov AG; Seredenina EM
    Kardiologiia; 2010; 50(6):41-7. PubMed ID: 20659026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
    Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
    J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol].
    Belenkov IuN; Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Narusov OIu; Baklanova NA; Masenko VP
    Kardiologiia; 2003; 43(10):10-21. PubMed ID: 14593351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
    Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
    Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.